Open Access iconOpen Access

REVIEW

crossmark

Opportunities and challenges of CD47-targeted therapy in cancer immunotherapy

QIUQIANG CHEN1,*, XUEJUN GUO2, WENXUE MA3,*

1 Key Laboratory for Translational Medicine, The First Affiliated Hospital, Huzhou University School of Medicine, Huzhou, 313000, China
2 Department of Hematology, Puyang Youtian General Hospital, Puyang, 457001, China
3 Department of Medicine, Moores Cancer Center, Sanford Stem Cell Institute, University of California San Diego, La Jolla, San Diego, 92093, USA

* Corresponding Authors: Qiuqiang Chen, email; Wenxue Ma, email

TSP_OR_42383.pdf

  • 3180

    View

  • 759

    Download

  • 0

    Like

Share Link